We are live on ! Find out more
NC

Naman Capital Portfolio holdings

AUM $360M
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+27.43%
3 Year Est. Return
+106.06%
5 Year Est. Return
+122.61%
10 Year Est. Return
AUM
$104M
AUM Growth
+$2.95M
Cap. Flow
-$2.29M
Cap. Flow %
-2.19%
Top 10 Hldgs %
89.69%
Holding
13
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.29M

Sector Composition

Rank Sector Weight
1 Healthcare 39.88%
2 Technology 19.5%
3 Consumer Staples 11.15%
4 Financials 7.59%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SH icon
1
ProShares Short S&P500
SH
$907M
$15.6M 14.95%
162,500
ATVI
2
DELISTED
Activision Blizzard
ATVI
$11.9M 11.38%
200,000
GILD icon
3
Gilead Sciences
GILD
$162B
$11M 10.58%
170,000
MRK icon
4
Merck
MRK
$322B
$10.9M 10.45%
125,760
BMY icon
5
Bristol-Myers Squibb
BMY
$133B
$10.3M 9.84%
160,000
-40,000
-20% -$2.29M
PFE icon
6
Pfizer
PFE
$143B
$9.4M 9.01%
252,960
ORCL icon
7
Oracle
ORCL
$374B
$8.48M 8.12%
160,000
DIS icon
8
Walt Disney
DIS
$167B
$7.23M 6.93%
50,000
BRK.B icon
9
Berkshire Hathaway Class B
BRK.B
$1.1T
$4.53M 4.34%
20,000
BUD icon
10
AB InBev
BUD
$170B
$4.28M 4.09%
52,300
K
11
DELISTED
Kellanova
K
$4.15M 3.98%
63,900
BRK.A icon
12
Berkshire Hathaway Class A
BRK.A
$1.1T
$3.4M 3.25%
10
KHC icon
13
Kraft Heinz
KHC
$30.7B
$3.21M 3.08%
100,000

Similar funds

Naman Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Naman Capital held 13 positions worth $104M, up 2.9% from $101M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 0%. Naman Capital opened no new positions and made no exits, leaving the 13-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 39% a quarter earlier, followed by Technology and Consumer Staples.

  • Naman Capital's biggest Q4 2019 reduction was Bristol-Myers Squibb, cutting an estimated $2.29M.
  • Naman Capital's ten largest holdings make up 90% of its $104M portfolio in Q4 2019.
  • Naman Capital opened 0 new positions and closed 0 in Q4 2019.
  • Naman Capital's portfolio value rose 2.9% quarter-over-quarter to $104M.

Based on Naman Capital's 13F filing for Q4 2019, filed 7 Oct 2022.